How device manufacturers can leverage price transparency data ft. Boston Scientific

Medical device manufacturers face a constant challenge: incomplete visibility into the complex reimbursement dynamics of their products. The result? A weakened pricing strategy and slow market growth.

In this session, Bill Webb (Boston Scientific) joins Carter Cowardin and Nicole Fitzsimmons (Turquoise Health) to walk through practical ways to turn public price transparency files into a competitive asset.

We cover:

• How new legislation impacts device reimbursement analysis
• How to find and evaluate negotiated rates for your devices in publicly available payer and hospital files
• Strategies for addressing data quality challenges and getting to clean, decision-ready insights